Cohizon Life Sciences Limited - Company Profile

It is a chemicals and materials public limited company based in Mumbai, Maharashtra, India, established in 1983.
1983 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Cohizon Life Sciences Limited

Cohizon Life Sciences Limited, a active public limited company, was established on 17 September 1983 in Mumbai, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U51900MH1983PLC030874. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹11.02 Cr and a paid-up capital of ₹3.18 Cr.

Formerly known as Sajjan Impex Pvt Limited, Sajjan Impex Limited. It upholds a compliant status. Employing 960 professional, Its leadership includes Rajesh Kumar Srivastava (Ceo), Steven Andre J Buyse (Director), Anant Jain (Director). Past directors included Rajesh Kumar Srivastava, Raghunathan Ananthanarayanan, Pawan Kumar Agarwal. It holds ₹356.00 Cr open charges and ₹151.85 Cr settled loans. Its latest AGM occurred on 20 August 2025, with the balance sheet filed on 31 March 2025. It is based at Urmi Estate, Tower A, 14Th Floor, 95, Ganpatrao Kadam Marg, Lower Parel (W, ), Mumbai, Maharashtra, 400013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51900MH1983PLC030874

  • Registration Number

    030874

  • Incorporation Date

    17 September 1983

  • Authorized Capital

    ₹11.02 Cr

  • Paid-Up Capital

    ₹3.18 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 11.02 Cr
  • Paid Up Capital ₹ 3.18 Cr
  • Company Age 42 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 356.00 Cr
  • Satisfied Charges ₹ 151.85 Cr
  • Revenue Growth **** -27.77%
  • Profit Growth **** -61.54%
  • Ebitda **** -54.54%
  • Net Worth 0.43%
  • Total Assets **** 3.85%
Company report

Cohizon Life Sciences Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Cohizon Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cohizon Life Sciences Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Kumar Srivastava Ceo 17 Apr 2024 Current
Steven Andre J Buyse Director 25 May 2022 Current
Anant Jain Director 25 May 2022 Current
Rajan Hamir Gajaria Director 22 Feb 2024 Current
Anurag Surana Director 25 Nov 2023 Current
Dirk Backhaus Director 26 Jun 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 21 Aug 2024 Past
Pramod Abcsdd Additional Director 25 May 2022 Past
Pramod Abcsdd Cfo 10 Jul 2024 Past
Pramod Abcsdd Director 25 May 2022 Past
Pramod Abcsdd Director 19 Dec 2014 Past
Pramod Abcsdd Additional Director 10 Oct 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cohizon Life Sciences.

Cohizon Life Sciences Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 27.77% decrease. The company also saw a substantial fall in profitability, with a 61.54% decrease in profit. The company's net worth moved up by a moderate rise of 0.43%.

Cohizon Life Sciences revenue growth over time
Cohizon Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -27.77%
*******
*******
*******
*******
Revenue from Operations
*******
 -29.46%
*******
*******
*******
*******
Total Assets
*******
 3.85%
*******
*******
*******
*******
Profit or Loss
*******
 -61.54%
*******
*******
*******
*******
Net Worth
*******
 0.43%
*******
*******
*******
*******
EBITDA
*******
 -54.54%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cohizon Life Sciences?

In 2024, Cohizon Life Sciences had a promoter holding of 88.81% and a public holding of 11.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,560,000,000.00

Satisfied Charges

₹1,518,500,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 200.00 Cr
  • Others : 81.00 Cr
  • Citi Bank N.A. : 75.00 Cr
Latest Charge Details
Date Lender Amount Status
09 Jun 2025 Axis Bank Limited ₹50.00 Cr Open
13 Nov 2024 Others ₹50.00 Cr Open
14 Jun 2023 Axis Bank Limited ₹150.00 Cr Open
06 Dec 2022 Others ₹1.00 Cr Open
04 Jan 2020 Others ₹30.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Cohizon Life Sciences?

Cohizon Life Sciences has a workforce of 960 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cohizon Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cohizon Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cohizon Life Sciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Cohizon Life Sciences Limited last Annual general meeting of members was held on 20 Aug 2025 as per latest MCA records. was documented.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 50.00 Cr with Charge ID 101113011 was registered on 09 Jun 2025. was documented.

  • Director Appointment

    Progress on Chandra Bose Bhardwaj was appointed as a Whole-time director was appointed as a Whole-time director on 27 May 2025 & has been associated with this company since 10 months 22 days . was documented.

  • Charges

    A charge registered on 15 Oct 2009 via Charge ID 10182498 with Standard Chartered Bank was fully satisfied on 03 Apr 2025. was recorded as a recent event.

  • Balance Sheet

    The activity Cohizon Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Neha Sureka was appointed as a Additional Director was appointed as a Additional Director on 26 Feb 2025 & has been associated with this company since 1 year 1 month . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cohizon Life Sciences Limited?

The CIN of Cohizon Life Sciences Limited is U51900MH1983PLC030874.

Where is Cohizon Life Sciences Limited headquartered?

Cohizon Life Sciences Limited is headquartered at Urmi Estate, Tower A, 14Th Floor, 95, Ganpatrao Kadam Marg, Lower Parel (W, ), Mumbai, Maharashtra, 400013.

When was Cohizon Life Sciences Limited incorporated?

Cohizon Life Sciences Limited was incorporated on 17 September 1983.

Who are the current directors of Cohizon Life Sciences Limited?

The current directors of Cohizon Life Sciences Limited are

What is the primary industry of Cohizon Life Sciences Limited?

The primary industry of Cohizon Life Sciences Limited is Manufacturing.

Is Cohizon Life Sciences Limited a listed company?

Cohizon Life Sciences Limited is unlisted.

What is the capital structure of Cohizon Life Sciences Limited?

The authorized capital of Cohizon Life Sciences Limited is ₹11.02 Cr, and the paid-up capital is ₹3.18 Cr.

What is the compliance status of Cohizon Life Sciences Limited?

The compliance status of Cohizon Life Sciences Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available